MENU
+Compare
SLN
Stock ticker: NASDAQ
AS OF
Apr 23 closing price
Price
$3.32
Change
+$0.27 (+8.85%)
Capitalization
134.59M

SLN Silence Therapeutics Plc Forecast, Technical & Fundamental Analysis

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SLN with price predictions
Apr 23, 2025

SLN's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for SLN moved out of oversold territory on April 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 28 similar instances when the indicator left oversold territory. In of the 28 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 15, 2025. You may want to consider a long position or call options on SLN as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SLN just turned positive on April 14, 2025. Looking at past instances where SLN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SLN advanced for three days, in of 196 cases, the price rose further within the following month. The odds of a continued upward trend are .

SLN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SLN entered a downward trend on April 22, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.075) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (3.261) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SLN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SLN is expected to report earnings to rise 11.14% to -7 cents per share on March 13

Silence Therapeutics Plc SLN Stock Earnings Reports
Q4'23
Est.
$-0.08
Q3'23
Beat
by $0.10
Q2'23
Beat
by $0.05
Q1'23
Beat
by $0.03
Q4'22
Beat
by $0.46
The last earnings report on November 14 showed earnings per share of -7 cents, beating the estimate of -17 cents. With 279.78K shares outstanding, the current market capitalization sits at 134.59M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
72 Hammersmith Road
Phone
+44 2034576900
Employees
109
Web
https://www.silence-therapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTNSX11.91N/A
N/A
Russell Inv Tax-Managed Intl Eq S
PWETX13.25N/A
N/A
PACE International Em Mkts Eq P2
WFILX46.64N/A
N/A
Allspring Index A
FCIVX16.05N/A
N/A
Frontier MFG Core Infrastructure Service
WWMCX10.24N/A
N/A
Westwood Quality Midcap Institutional

SLN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+9.84%
CLLS - SLN
43%
Loosely correlated
+1.39%
RCKT - SLN
40%
Loosely correlated
+2.44%
CMVLF - SLN
38%
Loosely correlated
N/A
NGNE - SLN
38%
Loosely correlated
+11.79%
IDYA - SLN
36%
Loosely correlated
+0.91%
More